Abstract
Mitochondrial DNA encodes genes that are de facto metabolic enzymes and are currently emerging as pivotal players in the origin, progression, and outcome of human cancers. We here revise the multifaceted implications of mitochondrial mutations on the metabolic reprogramming cancer cells must undergo to adapt and proliferate. The sources of such mutations and the processes that govern their positive selection are described, along with the consequences that a deranged respiratory metabolism may have on the remodeling that follows oncogenes activation or tumor suppressors ablation. Ultimately, we dwell on the peculiar features of oncocytic tumors, one of the most relevant yet mysterious models to functionally investigate the role of mitochondrial mutations in cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aanen DK, Maas MF (2012) Recruitment of healthy mitochondria fuels transmissible cancers. Trends Genet 28:1–6
Akhtar M, Kott E (1979) Oncocytoma of kidney. Urology 14:397–400
Alderson NL, Wang Y, Blatnik M, Frizzell N, Walla MD, Lyons TJ et al (2006) S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. Arch Biochem Biophys 450:1–8
Alexeyev M, Shokolenko I, Wilson G, LeDoux S (2013) The maintenance of mitochondrial DNA integrity—critical analysis and update. Cold Spring Harb Perspect Biol 5:a012641
Alsbeih GA, Al-Harbi NM, El-Sebaie MM, Al-Rajhi NM, Al-Hadyan KS, Abu-Amero KK (2009) Involvement of mitochondrial DNA sequence variations and respiratory activity in late complications following radiotherapy. Clin Cancer Res 15:7352–7360
Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A et al (2008) OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain 131:338–351
Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG (2002) Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 21:7839–7849
Arnold RS, Sun Q, Sun CQ, Richards JC, O’Hearn S, Osunkoya AO et al (2013) An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen and proliferation. Biomed Res Int 2013:239257
Arnould T, Vankoningsloo S, Renard P, Houbion A, Ninane N, Demazy C et al (2002) CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J 21:53–63
Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG et al (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357:1181–1182
Baradaran R, Berrisford JM, Minhas GS, Sazanov LA (2013) Crystal structure of the entire respiratory complex I. Nature 494:443–448
Bartoletti-Stella A, Mariani E, Kurelac I, Maresca A, Caratozzolo MF, Iommarini L et al (2013) Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1alpha. Cell Death Dis 4:e663
Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A et al (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848–851
Bellizzi D, D’Aquila P, Giordano M, Montesanto A, Passarino G (2012) Global DNA methylation levels are modulated by mitochondrial DNA variants. Epigenomics 4:17–27
Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R et al (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107–120
Biswas G, Adebanjo OA, Freedman BD, Anandatheerthavarada HK, Vijayasarathy C, Zaidi M et al (1999) Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J 18:522–533
Boesch P, Weber-Lotfi F, Ibrahim N, Tarasenko V, Cosset A, Paulus F et al (2010) DNA repair in organelles: pathways, organization, regulation, relevance in disease and aging. Biochim Biophys Acta 1813:186–200
Bonnet C, Kaltimbacher V, Ellouze S, Augustin S, Benit P, Forster V et al (2007) Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complex I or v subunits. Rejuvenation Res 10:127–144
Brandon M, Baldi P, Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25:4647–4662
Bungard D, Fuerth BJ, Zeng PY, Faubert B, Maas NL, Viollet B et al (2010) Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 329:1201–1205
Burney S, Caulfield JL, Niles JC, Wishnok JS, Tannenbaum SR (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424:37–49
Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85–95
Calabrese C, Iommarini L, Kurelac I, Calvaruso MA, Capristo M, Lollini PL et al (2013) Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells. Cancer Metab 1:11
Calabrese C, Simone D, Diroma MA, Santorsola M, Guttà C, Gasparre G, Picardi E, Pesole G, Attimonelli M (2014) MToolBox: a highly automated pipeline for heteroplasmy annotation and prioritization analysis of human mitochondrial variants in high-throughput sequencing. Bioinformatics pii:btu483
Campbell CT, Kolesar JE, Kaufman BA (2012) Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim Biophys Acta 1819:921–929
Canter JA, Kallianpur AR, Parl FF, Millikan RC (2005) Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65:8028–8033
Carelli V, Baracca A, Barogi S, Pallotti F, Valentino ML, Montagna P et al (2002) Biochemical-clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation. Arch Neurol 59:264–270
Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang P (2003) Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 17:1437–1447
Cavalli LR, Varella-Garcia M, Liang BC (1997) Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ 8:1189–1198
Cervera AM, Bayley JP, Devilee P, McCreath KJ (2009) Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol Cancer 8:89
Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM et al (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275:25130–25138
Chatterjee A, Dasgupta S, Sidransky D (2011) Mitochondrial subversion in cancer. Cancer Prev Res (Phila) 4:638–654
Chatterjee A, Mambo E, Sidransky D (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25:4663–4674
Chen PL, Chen CF, Chen Y, Guo XE, Huang CK, Shew JY et al (2012) Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan. Oncogene 32:1193–1201
Chiarugi A, Dolle C, Felici R, Ziegler M (2012) The NAD metabolome—a key determinant of cancer cell biology. Nat Rev Cancer 12:741–752
Chiche J, Brahimi-Horn MC, Pouyssegur J (2010) Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 14:771–794
Chinnery PF, Elliott HR, Hudson G, Samuels DC, Relton CL (2012) Epigenetics, epidemiology and mitochondrial DNA diseases. Int J Epidemiol 41:177–187
Cline SD (2012) Mitochondrial DNA damage and its consequences for mitochondrial gene expression. Biochim Biophys Acta 1819:979–991
Cloos CR, Daniels DH, Kalen A, Matthews K, Du J, Goswami PC et al (2009) Mitochondrial DNA depletion induces radioresistance by suppressing G2 checkpoint activation in human pancreatic cancer cells. Radiat Res 171:581–587
Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG (2001) High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28:147–150
Cook CC, Higuchi M (2012) The awakening of an advanced malignant cancer: an insult to the mitochondrial genome. Biochim Biophys Acta 1820:652–662
Copeland WC, Ponamarev MV, Nguyen D, Kunkel TA, Longley MJ (2003) Mutations in DNA polymerase gamma cause error prone DNA synthesis in human mitochondrial disorders. Acta Biochim Pol 50:155–167
Cuezva JM, Ortega AD, Willers I, Sanchez-Cenizo L, Aldea M, Sanchez-Arago M (2009) The tumor suppressor function of mitochondria: translation into the clinics. Biochim Biophys Acta 1792:1145–1158
Damiani S, Eusebi V, Losi L, D’Adda T, Rosai J (1998) Oncocytic carcinoma (malignant oncocytoma) of the breast. Am J Surg Pathol 22:221–230
Dasgupta S, Hoque MO, Upadhyay S, Sidransky D (2008) Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 68:700–706
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11–20
DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104:19345–19350
Denver DR, Morris K, Lynch M, Vassilieva LL, Thomas WK (2000) High direct estimate of the mutation rate in the mitochondrial genome of Caenorhabditis elegans. Science 289:2342–2344
Desler C, Munch-Petersen B, Stevnsner T, Matsui S, Kulawiec M, Singh KK et al (2007) Mitochondria as determinant of nucleotide pools and chromosomal stability. Mutat Res 625:112–124
Elachouri G, Vidoni S, Zanna C, Pattyn A, Boukhaddaoui H, Gaget K et al (2011) OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 21:12–20
Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR et al (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892–3899
Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z et al (2013) AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab 17:113–124
Feron O (2009) Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 92:329–333
Freyer C, Cree LM, Mourier A, Stewart JB, Koolmeister C, Milenkovic D et al (2012) Variation in germline mtDNA heteroplasmy is determined prenatally but modified during subsequent transmission. Nat Genet 44:1282–1285
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E et al (2010) Mitochondrial gateways to cancer. Mol Aspects Med 31:1–20
Gasparre G, Bonora E, Tallini G, Romeo G (2010a) Molecular features of thyroid oncocytic tumors. Mol Cell Endocrinol 321:67–76
Gasparre G, Hervouet E, de Laplanche E, Demont J, Pennisi LF, Colombel M et al (2008) Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet 17:986–995
Gasparre G, Iommarini L, Porcelli AM, Lang M, Ferri GG, Kurelac I et al (2009) An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells. Hum Mutat 30:391–396
Gasparre G, Kurelac I, Capristo M, Iommarini L, Ghelli A, Ceccarelli C et al (2011) A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function. Cancer Res 71:6220–6229
Gasparre G, Porcelli AM, Bonora E, Pennisi LF, Toller M, Iommarini L et al (2007) Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci USA 104:9001–9006
Gasparre G, Romeo G, Rugolo M, Porcelli AM (2010b) Learning from oncocytic tumors: why choose inefficient mitochondria? Biochim Biophys Acta 1807:633–642
Gochhait S, Bhatt A, Sharma S, Singh YP, Gupta P, Bamezai RN (2008) Concomitant presence of mutations in mitochondrial genome and p53 in cancer development—a study in north Indian sporadic breast and esophageal cancer patients. Int J Cancer 123:2580–2586
Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23:2891–2906
Green DR, Kroemer G (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458:1127–1130
Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626–629
Guerra F, Kurelac I, Cormio A, Zuntini R, Amato LB, Ceccarelli C et al (2011) Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Hum Mol Genet 20:2394–2405
Guerra F, Perrone AM, Kurelac I, Santini D, Ceccarelli C, Cricca M et al (2012) Mitochondrial DNA mutation in serous ovarian cancer: implications for mitochondria-coded genes in chemoresistance. J Clin Oncol 30:e373–e378
Guha M, Avadhani NG (2013) Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion 13:577–591
Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G et al (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25:460–470
Guo JY, Karsli-Uzunbas G, Mathew R, Aisner SC, Kamphorst JJ, Strohecker AM et al (2013) Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 27:1447–1461
Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD et al (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1:401–408
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hardie DG (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25:1895–1908
Hasmann M, Schemainda I (2003) FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63:7436–7442
Hazkani-Covo E, Zeller RM, Martin W (2010) Molecular poltergeists: mitochondrial DNA copies (numts) in sequenced nuclear genomes. PLoS Genet 6:e1000834
He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE et al (2010) Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464:610–614
Higuchi M, Manna SK, Sasaki R, Aggarwal BB (2002) Regulation of the activation of nuclear factor kappaB by mitochondrial respiratory function: evidence for the reactive oxygen species-dependent and -independent pathways. Antioxid Redox Signal 4:945–955
Hill BG, Benavides GA, Lancaster JR Jr, Ballinger S, Dell’Italia L, Jianhua Z et al (2012) Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem 393:1485–1512
Horton TM, Petros JA, Heddi A, Shoffner J, Kaufman AE, Graham SD Jr et al (1996) Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer 15:95–101
Icard P, Lincet H (2012) A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. Biochim Biophys Acta 1826:423–433
Imai S, Armstrong CM, Kaeberlein M, Guarente L (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795–800
Imanishi H, Hattori K, Wada R, Ishikawa K, Fukuda S, Takenaga K et al (2011) Mitochondrial DNA mutations regulate metastasis of human breast cancer cells. PLoS One 6:e23401
Iommarini L, Calvaruso MA, Kurelac I, Gasparre G, Porcelli AM (2012) Complex I impairment in mitochondrial diseases and cancer: parallel roads leading to different outcomes. Int J Biochem Cell Biol 45:47–63
Iommarini L, Kurelac I, Capristo M, Calvaruso MA, Giorgio V, Bergamini C, Ghelli A, Nanni P, De Giovanni C, Carelli V, Fato R, Lollini PL, Rugolo M, Gasparre G, Porcelli AM (2014) Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Hum Mol Genet 23(6):1453–1466
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143–153
Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H et al (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661–664
Jandova J, Eshaghian A, Shi M, Li M, King LE, Janda J et al (2012a) Identification of an mtDNA mutation hot spot in UV-induced mouse skin tumors producing altered cellular biochemistry. J Invest Dermatol 132:421–428
Jandova J, Janda J, Sligh JE (2012b) Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis. Exp Cell Res 318:2215–2225
Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177–185
Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV et al (2007) A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315:525–528
Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S et al (2012) Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483:484–488
Komar AA (2007) Genetics. SNPs, silent but not invisible. Science 315:466–467
Kulawiec M, Owens KM, Singh KK (2009a) Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Ther 8:1378–1385
Kulawiec M, Owens KM, Singh KK (2009b) mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J Hum Genet 54:647–654
Kurelac I, Lang M, Zuntini R, Calabrese C, Simone D, Vicario S et al (2011) Searching for a needle in the haystack: comparing six methods to evaluate heteroplasmy in difficult sequence context. Biotechnol Adv 30:363–371
Kurelac I, MacKay A, Lambros MB, Di Cesare E, Cenacchi G, Ceccarelli C et al (2013) Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas. Hum Mol Genet 22:226–238
Kwong JQ, Henning MS, Starkov AA, Manfredi G (2007) The mitochondrial respiratory chain is a modulator of apoptosis. J Cell Biol 179:1163–1177
Laloi-Michelin M, Meas T, Ambonville C, Bellanne-Chantelot C, Beaufils S, Massin P et al (2009) The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab 94:3025–3030
Lang M, Sazzini M, Calabrese FM, Simone D, Boattini A, Romeo G et al (2012) Polymorphic NumtS trace human population relationships. Hum Genet 131:757–771
Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB et al (2012) Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci USA 109:14087–14091
Lascaro D, Castellana S, Gasparre G, Romeo G, Saccone C, Attimonelli M (2008) The RHNumtS compilation: features and bioinformatics approaches to locate and quantify Human NumtS. BMC Genomics 9:267
Lebedeva MA, Eaton JS, Shadel GS (2009) Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim Biophys Acta 1787:328–334
Li Y, Weibing S, Liu H, Hongli J, Zhuosheng L, Yadong W et al (2008) Mitochondrial DNA from colorectal cancer cells promotes the malignant phenotype of NIH3T3 cells. Cell Biol Int 32:979–983
Liu J, Wang LD, Sun YB, Li EM, Xu LY, Zhang YP et al (2012) Deciphering the signature of selective constraints on cancerous mitochondrial genome. Mol Biol Evol 29:1255–1261
Liu VW, Wang Y, Yang HJ, Tsang PC, Ng TY, Wong LC et al (2003) Mitochondrial DNA variant 16189T > C is associated with susceptibility to endometrial cancer. Hum Mutat 22:173–174
Losman JA, Looper RE, Koivunen P, Lee S, Schneider RK, McMahon C et al (2013) (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339:1621–1625
Lozy F, Karantza V (2012) Autophagy and cancer cell metabolism. Semin Cell Dev Biol 23:395–401
Lu C, Thompson CB (2012) Metabolic regulation of epigenetics. Cell Metab 16:9–17
Lu J, Sharma LK, Bai Y (2009) Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 19:802–815
Ma Y, Bai RK, Trieu R, Wong LJ (2010) Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim Biophys Acta 1797:29–37
Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT et al (2005) Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1:393–399
Marucci G, Maresca A, Caporali L, Farnedi A, Betts CM, Morandi L et al (2013) Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number. Hum Pathol 44:1867–1876
Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O et al (2006) p53 regulates mitochondrial respiration. Science 312:1650–1653
Memmott RM, Dennis PA (2009) Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal 21:656–664
Minocherhomji S, Tollefsbol TO, Singh KK (2012) Mitochondrial regulation of epigenetics and its role in human diseases. Epigenetics 7:326–334
Mizutani S, Miyato Y, Shidara Y, Asoh S, Tokunaga A, Tajiri T et al (2009) Mutations in the mitochondrial genome confer resistance of cancer cells to anticancer drugs. Cancer Sci 100:1680–1687
Moraes CT, Dey R, Barrientos A (2001) Transmitochondrial technology in animal cells. Methods Cell Biol 65:397–412
Morais R, Zinkewich-Peotti K, Parent M, Wang H, Babai F, Zollinger M (1994) Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res 54:3889–3896
Mullen AR, Wheaton WW, ** ES, Chen PH, Sullivan LB, Cheng T et al (2011) Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481:385–388
Nair J, Strand S, Frank N, Knauft J, Wesch H, Galle PR et al (2005) Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 26:1307–1315
Naviaux RK (2008) Mitochondrial control of epigenetics. Cancer Biol Ther 7:1191–1193
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187–197
Park JS, Sharma LK, Li H, **ang R, Holstein D, Wu J et al (2009) A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 18:1578–1589
Partridge MA, Huang SX, Kibriya MG, Ahsan H, Davidson MM, Hei TK (2009) Environmental mutagens induced transversions but not transitions in regulatory region of mitochondrial DNA. J Toxicol Environ Health A 72:301–304
Payne BA, Wilson IJ, Yu-Wai-Man P, Coxhead J, Deehan D, Horvath R et al (2013) Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet 22:384–390
Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS et al (2006) Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 175:913–923
Pereira L, Freitas F, Fernandes V, Pereira JB, Costa MD, Costa S et al (2009) The diversity present in 5140 human mitochondrial genomes. Am J Hum Genet 84:628–640
Pereira L, Soares P, Maximo V, Samuels DC (2012) Somatic mitochondrial DNA mutations in cancer escape negative selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors. BMC Cancer 12:53
Pesole G, Allen JF, Lane N, Martin W, Rand DM, Schatz G et al (2012) The neglected genome. EMBO Rep 13:473–474
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J et al (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102:719–724
Petruzzella V, Carrozzo R, Calabrese C, Dell’Aglio R, Trentadue R, Piredda R et al (2012) Deep sequencing unearths nuclear mitochondrial sequences under Leber’s hereditary optic neuropathy-associated false heteroplasmic mitochondrial DNA variants. Hum Mol Genet 21:3753–3764
Picardi E, Pesole G (2012) Mitochondrial genomes gleaned from human whole-exome sequencing. Nat Methods 9:523–524
Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD et al (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20:291–293
Porcelli AM, Ghelli A, Ceccarelli C, Lang M, Cenacchi G, Capristo M et al (2010) The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization. Hum Mol Genet 19:1019–1032
Raimundo N, Song L, Shutt TE, McKay SE, Cotney J, Guan MX et al (2012) Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness. Cell 148:716–726
Ray PD, Huang BW, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24:981–990
Rossi ED, Martini M, Straccia P, Raffaelli M, Pennacchia I, Marrucci E et al (2013) The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience. Eur J Endocrinol 169:649–655
Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T (2003) Mitochondrial threshold effects. Biochem J 370:751–762
Rubino F, Piredda R, Calabrese FM, Simone D, Lang M, Calabrese C et al (2012) HmtDB, a genomic resource for mitochondrion-based human variability studies. Nucleic Acids Res 40:D1150–D1159
Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303:223–226
Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, Bandelt HJ (2005) A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2:e296
Samuels DC, Han L, Li J, Quanghu S, Clark TA, Shyr Y et al (2013) Finding the lost treasures in exome sequencing data. Trends Genet 29:593–599
Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, LeBoeuf SE, Gay LJ et al (2013) Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest 123:1068–1081
Savagner F, Franc B, Guyetant S, Rodien P, Reynier P, Malthiery Y (2001) Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors. J Clin Endocrinol Metab 86:4920–4925
Schon EA, DiMauro S, Hirano M (2012) Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 13:878–890
Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD et al (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77–85
Semenza GL, Roth PH, Fang HM, Wang GL (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757–23763
Sharma LK, Fang H, Liu J, Vartak R, Deng J, Bai Y (2011) Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation. Hum Mol Genet 20:4605–4616
Shay JW, Werbin H (1987) Are mitochondrial DNA mutations involved in the carcinogenic process? Mutat Res 186:149–160
Shen YH, Wang XL, Wilcken DE (1998) Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett 433:125–131
Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G et al (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65:1655–1663
Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM (2011) DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci USA 108:3630–3635
Silbergeld DL, Mayberg MR, Berger MS, Ali-Osman F, Kelly WA, Shaw CM (1993) Pituitary oncocytomas: clinical features, characteristics in cell culture, and treatment recommendations. J Neurooncol 16:39–46
Simone D, Calabrese FM, Lang M, Gasparre G, Attimonelli M (2011) The reference human nuclear mitochondrial sequences compilation validated and implemented on the UCSC genome browser. BMC Genomics 12:517
Singh KK, Ayyasamy V, Owens KM, Koul MS, Vujcic M (2009) Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis. J Hum Genet 54:516–524
Skonieczna K, Malyarchuk BA, Grzybowski T (2012) The landscape of mitochondrial DNA variation in human colorectal cancer on the background of phylogenetic knowledge. Biochim Biophys Acta 1825:153–159
Smiraglia DJ, Kulawiec M, Bistulfi GL, Gupta SG, Singh KK (2008) A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther 7:1182–1190
Smolkova K, Jezek P (2012) The role of mitochondrial NADPH-dependent isocitrate dehydrogenase in cancer cells. Int J Cell Biol 2012:273947
Smolkova K, Plecita-Hlavata L, Bellance N, Benard G, Rossignol R, Jezek P (2011) Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol 43:950–968
St John JC, Facucho-Oliveira J, Jiang Y, Kelly R, Salah R (2010) Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells. Hum Reprod Update 16:488–509
Stafford P, Chen-Quin EB (2010) The pattern of natural selection in somatic cancer mutations of human mtDNA. J Hum Genet 55:605–612
Sun W, Zhou S, Chang SS, McFate T, Verma A, Califano JA (2009) Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma. Clin Cancer Res 15:476–484
Tallini G (1998) Oncocytic tumours. Virchows Arch 433:5–12
Tang S, Huang T (2010) Characterization of mitochondrial DNA heteroplasmy using a parallel sequencing system. Biotechniques 48:287–296
Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410
Torroni A, Achilli A, Macaulay V, Richards M, Bandelt HJ (2006) Harvesting the fruit of the human mtDNA tree. Trends Genet 22:339–345
Tuppen HA, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 1797:113–128
van Oven M, Kayser M (2009) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30:E386–E394
Vogel RO, Smeitink JA, Nijtmans LG (2007) Human mitochondrial complex I assembly: a dynamic and versatile process. Biochim Biophys Acta 1767:1215–1227
Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12:685–698
Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482–1488
Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407
Wang PY, Ma W, Park JY, Celi FS, Arena R, Choi JW et al (2013) Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med 368:1027–1032
Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269–270
Warburg O, Posener K, Negelein E (1924) Uber den Stoffwechsel der Carcinomzelle. Biochem Zeitschr 152:309–344
Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21:297–308
Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M et al (2010) Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 107:8788–8793
Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:1076–1080
Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK et al (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105:18782–18787
Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM et al (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci USA 108:19611–19616
Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313(Pt 1):17–29
Wong LJ, Boles RG (2005) Mitochondrial DNA analysis in clinical laboratory diagnostics. Clin Chim Acta 354:1–20
**ao M, Yang H, Xu W, Ma S, Lin H, Zhu H et al (2012) Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26:1326–1338
Yao YG, Salas A, Logan I, Bandelt HJ (2009) mtDNA data mining in GenBank needs surveying. Am J Hum Genet 85:929–933, author reply 33
Yen HC, Tang YC, Chen FY, Chen SW, Majima HJ (2005) Enhancement of cisplatin-induced apoptosis and caspase 3 activation by depletion of mitochondrial DNA in a human osteosarcoma cell line. Ann N Y Acad Sci 1042:516–522
Yu M (2012) Somatic mitochondrial DNA mutations in human cancers. Adv Clin Chem 57:99–138
Zaragoza MV, Fass J, Diegoli M, Lin D, Arbustini E (2010) Mitochondrial DNA variant discovery and evaluation in human Cardiomyopathies through next-generation sequencing. PLoS One 5:e12295
Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L et al (2007) Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA 104:7540–7545
Zu XL, Guppy M (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313:459–465
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Kurelac, I., Vidone, M., Girolimetti, G., Calabrese, C., Gasparre, G. (2015). Mitochondrial Mutations in Cancer Progression: Causative, Bystanders, or Modifiers of Tumorigenesis?. In: Mazurek, S., Shoshan, M. (eds) Tumor Cell Metabolism. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1824-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1824-5_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1823-8
Online ISBN: 978-3-7091-1824-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)